发明名称 |
BIBW 2992 FOR USE IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER |
摘要 |
The present invention relates to a method of treating patients suffering from triple negative breast cancer comprising administration of an effective amount of the irreversible EGFR/HER1 and HER2 inhibitor BIBW 2992 (1) to a person in need of such treatment, optionally in combination with the administration of a further chemotherapeutic agent (2), in combination with radiotherapy, radio-immunotherapy and/or tumour resection by surgery.
|
申请公布号 |
US2013012465(A1) |
申请公布日期 |
2013.01.10 |
申请号 |
US201013511172 |
申请日期 |
2010.12.06 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;HASLINGER CHRISTIAN;SOLCA FLAVIO;UTTENREUTHER-FISCHER MARTINA |
发明人 |
HASLINGER CHRISTIAN;SOLCA FLAVIO;UTTENREUTHER-FISCHER MARTINA |
分类号 |
A61K31/517;A61K31/664;A61K31/704;A61P35/00 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|